The Netherlands
Hypherdata, founded in 2019, is carving a niche in the AI and Big Data sectors, specifically within healthcare realms. With headquarters in The Netherlands, this company champions data-driven insights by licensing real-world data from a diverse array of healthcare providers. Their mission is succinctly encapsulated in their slogan: "License real-world data from Healthcare Data Providers across continents, data modalities, and medical areas."
Hypherdata is on the cusp of launching a proprietary platform that enhances data study management and facilitates interaction among stakeholders. This system promises to streamline administrative and compliance processes while emphasizing data security, allowing sensitive information to remain internally guarded. The platform's capabilities are likely to attract stakeholders across the healthcare ecosystem, from pharma entities to hospitals.
Recently, Hypherdata secured a €850.00K seed investment in August 2024, backed by investors like Nation 1 and CB ESPRi. This financial infusion stands as a testament to their innovative approach within the Life Sciences and Information Technology domains, positioning them for future growth.
